Angela Jefferson

Angela Jefferson, PhD, professor of Neurology and director of the Vanderbilt Memory and Alzheimer’s Center, has been awarded a $3.7 million, three-year grant from the National Institute on Aging (NIA) to support establishment of a prospective NIA-funded Alzheimer’s Disease Research Center (ADRC) at Vanderbilt University Medical Center. Read More

Vanderbilt's inaugural Alzheimer’s Disease Research Day drew more than 100 attendees to hear faculty lectures on subjects ranging from diet to brain modeling, take in short “data blitzes” on individual areas of research, and visit a 35-station poster session. Read More

Commonly thought to be harmless, enlargement of fluid-filled in the brain have been linked to cognitive problems in older adults. Read More

A new link between a support protein within the brain's white matter and known Alzheimer's biomarkers discovered by Angela Jefferson and colleagues bring researchers a step toward earlier and more precise detection of neuropathology underlying cognitive impairment that may lead to new targeted therapies Read More

A symptom related to hypertension may play a role in cognitive decline, according to new research by Angela Jefferson. Read More

The Howard Hughes Medical Institute has awarded 2018 Gilliam Fellowships for Advanced Study—created to ensure that a diverse and highly trained workforce is prepared to assume leadership roles in the sciences—to three Vanderbilt University doctoral students and their advisers. Read More

Research by a team of Vanderbilt University Medical Center (VUMC) scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer’s pathology first begins. Read More

A healthier heart could prevent Alzheimer’s disease, according to new research at Vanderbilt University Medical Center. Read More

A study of cognitive complaints in older adults showed that memory concerns from both the patient and an informant was most predictive of converting to Alzheimer’s disease or dementia within three years. Read More